Label: AFTER BITE WIPE INSECT STING RELIEF- benzocaine,alcohol swab

  • Category: HUMAN OTC DRUG LABEL

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated December 10, 2020

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • Active Ingredients

    Benzocaine, 6%

    SD alcohol, 60%

  • Purpose

    Topical Analgesic
    Antiseptic

  • Use

    • temporarily relieves pain and itching due to minor stings and insect bites
    • to help reduce bacteria on the skin
  • Warnings

    For external use only.

    Flammable, keep away from fire or flame.

  • Do not use

    • over large areas of the body
    • in the eyes
    • on broken skin or deep puncture wounds
  • Stop use and ask a doctor if

    condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days.

  • Keep out of reach of children

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • adults and children 2 year of age and older: apply to affected area not more than 3 to 4 times daily.
    • children under 2 years of age: consult a doctor
  • Other information

    Store at room temperature

  • Inactive Ingredient

    Purified water

  • PRINCIPAL DISPLAY PANEL

    Label

  • INGREDIENTS AND APPEARANCE
    AFTER BITE WIPE INSECT STING RELIEF 
    benzocaine,alcohol swab
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:90107-3623
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE6 mg  in 100 mg
    ALCOHOL (UNII: 3K9958V90M) (ALCOHOL - UNII:3K9958V90M) ALCOHOL60 mg  in 100 mg
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:90107-3623-11000 mg in 1 PACKAGE; Type 0: Not a Combination Product12/01/2020
    2NDC:90107-3623-2100 in 1 BOX12/01/2020
    21000 mg in 1 PACKET; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart333E12/01/2020
    Labeler - Adventure Ready Brands (064437304)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!